Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2007
08/21/2007US7258855 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed
08/16/2007WO2007092031A1 Stable pharmaceutical formulations of montelukast sodium
08/16/2007WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate
08/16/2007WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same
08/16/2007WO2007091176A1 Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives
08/16/2007WO2007076086A3 Tricyclic spiro compounds useful as transforming growth factor modulators
08/16/2007WO2007076053A3 Stable s-nitrosothiol formulations
08/16/2007WO2007075838A3 Pure and stable tiotropium bromide
08/16/2007WO2007007919A3 Heterocyclic janus kinase 3 inhibitors
08/16/2007WO2006124753A3 Antipyretic agents against vr1-antagonist-induced increases in body temperature
08/16/2007WO2006115509A3 Small molecule immunopotentiators and assays for their detection
08/16/2007WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments
08/16/2007US20070191493 Use of n-alkanols as activators of the cftr channel
08/16/2007US20070191478 Methods of treating cardio pulmonary diseases with NO group compounds
08/16/2007US20070191426 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation
08/16/2007US20070191392 Dipeptide nitrile cathespin k inhibitors
08/16/2007US20070191386 Bicyclo-pyrazole compounds specially pyrrolo[3,4-c]pyrazole or tetrahydropyridine[4,3-c]pyrazole derivatives; anticarcinogenic agents; N-{5-phenylacetyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}phenylacetamide; modulators of apoptosis; combinatorial chemical library with an isocyanate polystyrenic resin
08/16/2007US20070191310 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; 1-Stearoyl-2-{3-[2-(2,6-dichloroanilino)phenylacetamido]propanoyl}-sn-glycero-3-phosphocholine
08/16/2007US20070190612 31 Human Secreted Proteins
08/16/2007US20070190567 Treatment for asthma and allergy
08/16/2007US20070190106 Phosphorus-containing compounds & uses thereof
08/16/2007US20070190076 A bacterial preparation consisting of freeze dried, non-denatured Mycobacterium bovis and water, in an amount effective to stimulate leukocytic regulatory cells, used for the prevention and/or the treatment of cancer, autoimmune diseases, allergies and tuberculosis; vaccines
08/16/2007US20070190054 Prevention and treatment of complement-associated disorders
08/16/2007CA2641169A1 Antigenic gm-csf peptides and antibodies to gm-csf
08/16/2007CA2640665A1 Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives
08/16/2007CA2637815A1 Crystalline forms of ciclesonide
08/16/2007CA2635841A1 Stable pharmaceutical formulations of montelukast sodium
08/16/2007CA2629336A1 [4-(benzo[b]thiophen-2-yl)pyrimidin-2yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
08/15/2007EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
08/15/2007EP1818057A1 Stable pharmaceutical formulations of montelukast sodium
08/15/2007EP1818053A1 Preventive/remedy for allergic diseases
08/15/2007EP1818052A1 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others
08/15/2007EP1817282A1 Phenoxyacetic acid derivatives useful for treating respiratory diseases
08/15/2007EP1817279A2 17,20(z)-dehydro vitamin d analogs and their uses
08/15/2007EP1817278A2 2-methylene-18,19-dinor-1alfa-hydroxy-homopregnacalciferol and its uses
08/15/2007EP1817041A2 Tafi inhibitors and their use to treat pulmonary fibrosis
08/15/2007EP1817034A1 M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
08/15/2007EP1539759B1 Novel imidazopyridines and their use
08/15/2007EP1496059B1 Fused bicyclic pyrimidine derivatives
08/15/2007EP1448531B1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
08/15/2007EP1368028B1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
08/15/2007EP1343488B1 Treatment of statin side effects
08/15/2007EP1322596B1 Zwitterionic tachykinin receptor antagonists
08/15/2007CN1332018C Freezing dried mycobatctericsis preparation and its preparing method and use
08/15/2007CN1331857C Fused-polycyclic compounds
08/15/2007CN1331848C Tricyclic steroid hormone nuclear receptor modulators
08/15/2007CN1331535C Application of viscid serratia vaccine in preparing medicine for treating bronchial asthma
08/15/2007CN1331523C Compound stemona cough stopping medicine and its preparation method
08/15/2007CN1331522C Red tangerine peel medicine for treating sputum cough and its preparation method
08/15/2007CN1331512C Mixture of eliminating sputum and relieving asthma and preparation method
08/15/2007CN1331511C Dispersed snake gall tablets and their preparation
08/15/2007CN1331508C Decoction for treating tonsillitis
08/15/2007CN1331495C Throat-clearing lozenge
08/15/2007CN1331491C Ginseng and aconite transfusion for treating qi vacuity and yang desertion and its preparation method
08/15/2007CN1331485C Medicine for treating cold
08/15/2007CN101018566A Combinations comprising antimuscarinic agents and beta-adrenergic agonists
08/15/2007CN101018549A Cla-enriched milkfat and uses thereof
08/15/2007CN101015699A Polyethylene glycol-phosphatidyl ethanolamine polymer or medicinal acid addition salt and application thereof in pharmacy
08/15/2007CN101015698A Medicament using rare earth transferring complex compound as vector
08/15/2007CN101015693A Use of CD25 binding molecules in steroid-resistant patients.
08/15/2007CN101015691A Recombinant phages influenza vaccine
08/15/2007CN101015679A Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
08/15/2007CN101015660A Medicine for treating common cold
08/15/2007CN101015657A Use of rice carbon in pharmacy
08/15/2007CN101015631A Medicine of Longmu Qingfeiling
08/15/2007CN101015630A Traditional Chinese medicine soft capsule and its preparing process and quality controlling means
08/15/2007CN101015622A Medicinal use of radix rehmanniae total glucosides extractive and preparing method thereof
08/15/2007CN101015616A Chinese medicine composition for treating children pneumonia and preparing method thereof
08/15/2007CN101015615A Jingfang antiphlogistic powder for treating chicken respiratory infectious bronchitis and its preparing process
08/15/2007CN101015612A Traditional Chinese medicine agent for treating infantile bronchopneumonia
08/15/2007CN101015600A Desiccation process for tanreqin injection intermediates
08/15/2007CN101015595A Composition of schisandra fruit and asarum for treating asthma and preparing process thereof
08/15/2007CN101015594A Composition for treating asthma and preparing process thereof
08/15/2007CN101015590A Jiawei Fuzheng Jiedu powder for treating chicken renal infectious bronchitis and its preparing process
08/15/2007CN101015561A Compound genticin-micronomicin injection, preparing method and use thereof
08/15/2007CN101015559A Instant gelling agent for treating allergic rhinitis
08/15/2007CN101015558A Preparation of superfine prednisolone powder
08/15/2007CN101015554A 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-benzamide for treating pulmonary fibrosis
08/15/2007CN101015519A Loratadine oral compound medication composition
08/15/2007CN101015380A Producing method of health care beverage
08/14/2007US7257419 Method for attempting to establish a connection between a mobile station and a wireless communication system including a parameter identifying reason for a previously failed reconnection attempt and a parameter indicating a number of times that the reason occurred
08/14/2007US7256310 L-tartrate derivative; stable particle size distribution; reproducible dosing; can be stored under varying temperature and humidity conditions
08/14/2007US7256211 Containing a carboxy-substituted thiazolylthio group, e.g., 15 alpha ,13E)-9-oxo-15-hydroxy-16-(4-fluoro-3-phenylphenyl)-5-(4-carboxythiazol-2-yl)-1,2,3,4,17,18,19,20-octanol-5-thia-8-azaprost-13-ene; EP4 agonistic action and are useful for treating diseases including immunological disorders and asthma
08/14/2007US7256194 Compounds that inhibit factor Xa activity
08/14/2007US7256183 Administering a nucleotide receptor agonist (such as adenosine triphophate or uridine triphosphate); sinusitis, rhinitis, conjunctivitis, asthma, dermatitis, inflammatory collagen vascular diseases, glomerulonephritis; antiallergens
08/14/2007US7256043 Transfection complexes
08/14/2007US7256028 Methods for screening compounds that modulate lipid metabolism
08/14/2007US7255884 Composition for treatment of asthma
08/14/2007US7255868 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies
08/14/2007CA2223414C Heteroaryl diol acids as leukotriene antagonists
08/09/2007WO2007089018A1 Triazole derivative
08/09/2007WO2007088823A1 ABZYME TO HUMAN TNF-α AND USE THEREOF
08/09/2007WO2007088681A1 Ghrelin production promoter
08/09/2007WO2007088450A2 Chromane antagonist of the h-3 receptor
08/09/2007WO2007088019A1 Use of naphthyridine derivatives as medicaments
08/09/2007WO2007087689A1 A method of modulating cellular activity and agents for use therein
08/09/2007WO2007039760A3 Use of oligouronates for treating mucus hyperviscosity
08/09/2007WO2006081555A3 Methods of diagnosis and treatment for asthma, allergic rhinitis and other respiratory diseases based on haplotype association
08/09/2007WO2006042329A8 Crig polypeptide for prevention and treatment of complement-associated disorders
08/09/2007US20070185181 Treatment or prevention of hypotension and shock